Skip to main content
. 2023 Mar 15;18(1):nsad007. doi: 10.1093/scan/nsad007

Table 2.

Summary Statistics for ERP to Gain and Loss Trials

Gain Loss
Measurement M (SD) Range M (SD) Range
No. of trials
Baseline 29.36 (1.64) 18–30 29.32 (1.68) 19–30
Eight weeks 29.47 (1.51) 14–30 29.43 (1.51) 20–30
Data quality
SMEij
 Baseline 1.53 (0.41) 0.73–3.95 1.48 (0.55) 0.66–8.05
 Eight weeks 1.60 (0.46) 0.74–4.24 1.56 (0.47) 0.73–3.74
σij
 Baseline 8.25 (2.14) 3.80–16.77 7.99 (2.69) 3.45–36.87
 Eight weeks 8.65 (2.35) 3.91–22.83 8.44 (2.52) 3.99–20.48
Group-level internal consistency
Estimate 95% CI Estimate 95% CI
r xx
 Baseline 0.95 0.93
 Eight weeks 0.93 0.93
α
 Baseline 0.94 (0.93, 0.95) 0.94 (0.93, 0.95)
 Eight weeks 0.93 (0.92, 0.95) 0.93 (0.92, 0.95)
ϕk
 Baseline 0.93 (0.92, 0.94) 0.93 (0.92, 0.94)
 Eight weeks 0.93 (0.91, 0.94) 0.93 (0.91, 0.94)
ICC
 Baseline 0.32 (0.28, 0.36) 0.30 (0.27, 0.34)
 Eight weeks 0.28 (0.23, 0.32) 0.27 (0.23, 0.32)
Subject-level internal consistency
M (SD) Range M (SD) Range
ϕjk
 Baseline 0.93 (0.02) 0.81–0.96 0.93 (0.03) 0.58–0.96
 Eight weeks 0.92 (0.03) 0.77–0.97 0.92 (0.03) 0.79–0.97
ICC
 Baseline 0.33 (0.06) 0.18–0.49 0.32 (0.06) 0.06–0.46
 Eight weeks 0.30 (0.06) 0.10–0.48 0.30 (0.06) 0.11–0.48

Note: All estimates based on N = 276 at baseline and N = 187 at 8 weeks. SMEij = standard measurement error; σij = between-trial standard deviation; rxx = odd–even reliability with Spearman–Brown Prophecy adjustment; α = Cronbach’s alpha; ϕk = group-level dependability; ϕjk = subject-level dependability.